[CRYPTOCOCCAL MENINGITIS. RECENT OBSERVATIONS ON DIAGNOSIS AND TREATMENT].
Explore the source record for details and available documents.
Amphotericin B↗
Biomedical subjects
W T BUTLER
Publications and source records attributed to W T BUTLER.
POTASSIUM LOSS FROM HUMAN ERYTHROCYTES EXPOSED TO AMPHOTERICIN B.
Explore the source record for details and available documents.
Amphotericin B↗
RENAL HISTOPATHOLOGY ASSOCIATED WITH DIFFERENT DEGREES OF AMPHOTERICIN B TOXICITY IN THE DOG.
Explore the source record for details and available documents.
Amphotericin B↗
THE SITE OF ATTACHMENT OF HEXOSE IN TROPOCOLLAGEN.
Explore the source record for details and available documents.
Amino Acids↗
STUDIES ON ANTIBODY PRODUCTION. XI. VARIATION IN THE SECONDARY RESPONSE AS A FUNCTION OF THE LENGTH OF THE INTERVAL BETWEEN TWO ANTIGENIC STIMULI.
As the interval between two antigenic stimuli to mice is lengthened, the magnitude of the response to the second dose increases up to approximately 40 days; thereafter it remains at a fairly constant, high level.
Animals↗
STUDIES ON ANTIBODY PRODUCTION. XII. INHIBITION OF PRIMING BY DRUGS.
The effect of drugs upon the primary and the secondary antibody response to diphtheria toxoid in mice was studied using an experimental system previously described. Triethylenethiophosphoramide (thio-TEPA), chloramphenicol, 6-mercaptopurine, 8-azaguanine, and versenate were found to inhibit, partially or completely,"priming" for the secondary response. Thio-TEPA, chloramphenicol, and 6-mercaptopurine, in doses exceeding those effective in inhibiting priming, did not cause alteration of the secondary response when given only during the secondary response. However, when chloramphenicol and amethopterin were given for 5 days prior to and at least 5 days after the second antigen injection, slight suppression of peak secondary titers occurred. Therefore, drug dosages effective in suppressing priming had less effect on the secondary response. It thus appears that there is a real difference between "priming" and the induction of antibody synthesis.
Animals↗
INTRAVENOUS ADMINISTRATION OF AMPHOTERICIN B IN THE DOG.
Explore the source record for details and available documents.
Administration, Intravenous↗
CLINICO-PATHOLOGIC CONFERENCE FROM THE SCHOOL OF VETERINARY MEDICINE, UNIVERSITY OF PENNSYLVANIA.
Explore the source record for details and available documents.
Animals↗
DIAGNOSTIC AND PROGNOSTIC VALUE OF CLINICAL AND LABORATORY FINDINGS IN CRYPTOCOCCAL MENINGITIS, A FOLLOW-UP STUDY OF FORTY PATIENTS.
Explore the source record for details and available documents.
Amphotericin B↗
OPHTHALMOLOGIC COMPLICATIONS OF CRYPTOCOCCAL MENINGITIS.
Explore the source record for details and available documents.
Amphotericin B↗
NEPHROTOXICITY OF AMPHOTERICIN B; EARLY AND LATE EFFECTS IN 81 PATIENTS.
Explore the source record for details and available documents.
Amphotericin B↗
AMPHOTERICIN B TOXICITY; CHANGES IN RENAL FUNCTION.
Explore the source record for details and available documents.
Amphotericin B↗
AMPHOTERICIN B RENAL TOXICITY IN THE DOG.
Explore the source record for details and available documents.
Amphotericin B↗
COMPARISON OF RENAL TOXICITY OF TWO PREPARATIONS OF AMPHOTERICIN B.
Explore the source record for details and available documents.
Amphotericin B↗
LETHAL TOXICITY AND DOSE-RELATED AZOTEMIA DUE TO AMPHOTERICIN B IN DOGS.
Explore the source record for details and available documents.
Amphotericin B↗
The improved prognosis of cryptococcal meningitis with amphotericin B therapy.
Explore the source record for details and available documents.
Amphotericin B↗
HEMAGGLUTINATION STUDIES WITH FORMALINIZED ERYTHROCYTES. EFFECT OF BIS-DIAZO-BENZIDINE AND TANNIC ACID TREATMENT ON SENSITIZATION BY SOLUBLE ANTIGEN.
Explore the source record for details and available documents.
Antigens↗
NEPHROTOXIC TUBULAR DAMAGE AND CALCIUM DEPOSITION FOLLOWING AMPHOTERICIN B THERAPY.
Explore the source record for details and available documents.
Amphotericin B↗